Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Basic data given

Data source

Reference
Reference Type:
review article or handbook
Title:
Strategies for Identifying False Positive Responses in Predictive Skin Sensitization Tests
Author:
Basketter, D.A. et al.
Year:
1998
Bibliographic source:
Food and Chemical Toxicology 36(4):327 - 33

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
GLP compliance:
not specified
Type of study:
mouse local lymph node assay (LLNA)

Test material

1
Chemical structure
Reference substance name:
Octanoic acid
EC Number:
204-677-5
EC Name:
Octanoic acid
Cas Number:
124-07-2
Molecular formula:
C8H16O2
IUPAC Name:
octanoic acid

In vivo test system

Test animals

Species:
mouse
Strain:
CBA
Sex:
not specified

Study design: in vivo (LLNA)

Vehicle:
not specified
Concentration:
10, 25 and 50%
No. of animals per dose:
4
Details on study design:
RANGE FINDING TESTS:
- Irritation: in a human 4 h patch test (Basketter et al., 1997) octanoic acid showed a high irritation potential (68% of the panel responded to octanoic acid and 58% of the panel reacted to 25% sodium lauryl sulphate (positive control))

MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: 3H-methyl thymidine incorporation determined by β-scintillation
- Criteria used to consider a positive response: Evaluation criteria used were taken from Kimber and Basketter (1992)

TREATMENT PREPARATION AND ADMINISTRATION: 25 µL of the test or vehicle alone was applied to the dorsum of both ears. The application was repeated on days 2 and 3. On day 6, 20 µCi 3H-methyl thymidine in 250 µL phosphate buffered saline (PBS) was injected into the tail vein. 5 h later, the draining auricular lymph nodes were excised and pooled for each experimental group. A single cell suspension of pooled lymph node cells was prepared by gentle mechanical disaggregation and washed twice in PBS. After the final wash, pellets were resuspended in 5% trichloracetic acid (TCA) and incubated at 4 °C for 18 h. Pellets were resuspended in TCA and thymidine incorporation was measured.
Positive control substance(s):
other: analogue tests with other substances are also reported

Results and discussion

In vivo (LLNA)

Resultsopen allclose all
Parameter:
SI
Value:
0.7
Test group / Remarks:
10% test substance
Parameter:
SI
Value:
1
Test group / Remarks:
25% test substance
Parameter:
SI
Value:
1.6
Test group / Remarks:
50% test substance

Applicant's summary and conclusion

Interpretation of results:
other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
Conclusions:
CLP: not classified